Combination therapy with methotrexate and chloroquine in rheumatoid arthritis: A multicenter randomized placebo-controlled trial

Scandinavian Journal of Rheumatology

Volumn 23, Issue 5, 1994, Pages 231-236

  Ferraz, M B ^a   Pinheiro, G R C ^e   Helfenstein, M ^a   Albuquerque, E ^e   Rezende, C ^b   Roimicher, L ^d   Brandao, L ^b   Silva, S C ^e   Pinheiro, G C ^c   Atra, E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL HELIÓPOLIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d PAM Vila Izabel INAMPS ^*  (Brazil)

^e HOSPITAL GERAL DE BONSUCESSO   (Brazil)

Author keywords

Chloroquine; Clinical trials; Combination therapy; Functional ability; Methotrexate; Outcome measures; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; METHOTREXATE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CHLOROQUINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0028148788     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749409103721     Document Type: Article

References (33)

1. Remodeling the pyramid-a concept whose time has come
2. Remodeling the pyramid: the therapeutic target of rheumatoid arthritis
3. Rethinking rheumatic disease therapy
4. A combination of D-penicillamine and hydroxychloroquine for the treatment of rheumatoid arthritis
5. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis
6. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis-a comparative study
7. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis
8. Low dose cytotoxic drug combination therapy in intractable rheumatoid arthritis
9. Treatment of intractable rheumatoid arthritis with combined cyclosphosphamide, azathioprine and hydroxychloroquine
10. Experience with penicillamine and azathioprine in rheumatoid arthritis
11. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized. Placebo-controlled study
12. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide and sodium aurothiomalate
13. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial
14. Combination therapy for rheumatoid arthritis with low dose azathioprine and low dose D-penicillamine.-Results of single drug usage versus combination drug
15. A double blind controlled trial of adding hydroxichloroquine or placebo to patients with a suboptimal response after 6 months of IM gold
16. Prospective open longterm observation of rheumatoid arthritis patients treated with MTX or MTX + gold
17. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial
18. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis
19. Combination therapy in rheumatoid arthritis.-No benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy
20. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
21. Therapeutic criteria in rheumatoid arthritis
22. Cooperating Clinics Committee of the American Rheumatism Association: A seven-day variability study of 499 patients with peripheral rheumatoid arthritis
23. Cross-cultural reliability of the physical ability dimension of the Health Assessment Questionnaire
24. Longterm outcome of treating rheumatoid arthritis: results after 20 years
25. Does aggressive rheumatoid arthritis therapy affect outcome?
26. Evaluating combination drug therapy in rheumatoid arthritis
27. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses
28. The relative toxicity of disease modifying anti-rheumatic drugs (DMARDS)
29. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis
30. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?
31. Prospective study of hepatotoxicity in patients receiving methotrexate for rheumatoid arthritis.-An update
32. Prospective, longitudinal study of liver biopsies in 40 RA patients on MTS followed for 6.5 years